147 related articles for article (PubMed ID: 7480549)
1. Comparison of the spectrum of cognitive effects of alprazolam and adinazolam after single doses in healthy subjects.
Fleishaker JC; Garzone PD; Chambers JH; Sirocco K; Weingartner H
Psychopharmacology (Berl); 1995 Jul; 120(2):169-76. PubMed ID: 7480549
[TBL] [Abstract][Full Text] [Related]
2. Kinetics and dynamics of intravenous adinazolam, N-desmethyl adinazolam, and alprazolam in healthy volunteers.
Venkatakrishnan K; Culm KE; Ehrenberg BL; Harmatz JS; Corbett KE; Fleishaker JC; Greenblatt DJ
J Clin Pharmacol; 2005 May; 45(5):529-37. PubMed ID: 15831776
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of adinazolam and N-desmethyladinazolam after oral and intravenous dosing in healthy young and elderly volunteers.
Fleishaker JC; Hulst LK; Ekernäs SA; Grahnén A
J Clin Psychopharmacol; 1992 Dec; 12(6):403-14. PubMed ID: 1474178
[TBL] [Abstract][Full Text] [Related]
4. Psychomotor and memory effects of two adinazolam formulations assessed by a computerized neuropsychological test battery.
Fleishaker JC; Sisson TA; Sramek JJ; Conrad J; Veroff AE; Cutler NR
J Clin Pharmacol; 1993 May; 33(5):463-9. PubMed ID: 8331205
[TBL] [Abstract][Full Text] [Related]
5. Adinazolam pharmacokinetics and behavioral effects following administration of 20-60 mg oral doses of its mesylate salt in healthy volunteers.
Fleishaker JC; Phillips JP
Psychopharmacology (Berl); 1989; 99(1):34-9. PubMed ID: 2506603
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of adinazolam and N-desmethyladinazolam mesylate after single oral doses of each compound in healthy volunteers.
Fleishaker JC; Friedman H; Pollock SR; Smith TC
Clin Pharmacol Ther; 1990 Dec; 48(6):652-64. PubMed ID: 2249377
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic comparison of immediate-release and sustained-release adinazolam mesylate tablets after single- and multiple-dose administration.
Fleishaker JC; Wright CE
Pharm Res; 1992 Apr; 9(4):457-63. PubMed ID: 1495889
[TBL] [Abstract][Full Text] [Related]
8. [The cognitive effect of alprazolam in healthy volunteers].
Drabant S; Tömlo J; Tóth M; Péterfai E; Klebovich I
Acta Pharm Hung; 2006; 76(1):25-31. PubMed ID: 17094673
[TBL] [Abstract][Full Text] [Related]
9. Effects of probenecid on the pharmacokinetics and pharmacodynamics of adinazolam in humans.
Golden PL; Warner PE; Fleishaker JC; Jewell RC; Millikin S; Lyon J; Brouwer KL
Clin Pharmacol Ther; 1994 Aug; 56(2):133-41. PubMed ID: 8062489
[TBL] [Abstract][Full Text] [Related]
10. Effects of adinazolam and diazepam, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers.
Linnoila M; Stapleton JM; Lister R; Moss H; Lane E; Granger A; Greenblatt DJ; Eckardt MJ
Eur J Clin Pharmacol; 1990; 38(4):371-7. PubMed ID: 2344860
[TBL] [Abstract][Full Text] [Related]
11. The effects of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard.
File SE; Pellow S
Br J Pharmacol; 1985 Nov; 86(3):729-35. PubMed ID: 2866006
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant properties of the triazolobenzodiazepines alprazolam and adinazolam: studies on the olfactory bulbectomized rat model of depression.
O'Connor WT; Earley B; Leonard BE
Br J Clin Pharmacol; 1985; 19 Suppl 1():49S-56S. PubMed ID: 2859878
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain.
Owens MJ; Bissette G; Nemeroff CB
Synapse; 1989; 4(3):196-202. PubMed ID: 2575286
[TBL] [Abstract][Full Text] [Related]
14. Effects of buspirone and alprazolam on the cognitive performance of normal elderly subjects.
Hart RP; Colenda CC; Hamer RM
Am J Psychiatry; 1991 Jan; 148(1):73-7. PubMed ID: 1984710
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics and pharmacodynamics of adinazolam: multi-ethnic comparisons.
Ajir K; Smith M; Lin KM; Fleishaker JC; Chambers JH; Anderson D; Nuccio I; Zheng Y; Poland RE
Psychopharmacology (Berl); 1997 Feb; 129(3):265-70. PubMed ID: 9084065
[TBL] [Abstract][Full Text] [Related]
16. Comparison of adinazolam pharmacokinetics and effects in healthy and cirrhotic subjects.
Kroboth PD; Maxwell RA; Fleishaker JC; Van Thiel DH; Smith RB
J Clin Pharmacol; 1991 Jun; 31(6):580-6. PubMed ID: 1880225
[TBL] [Abstract][Full Text] [Related]
17. The lack of effect of smoking on the pharmacokinetics and pharmacodynamics of adinazolam and N-demethyladinazolam.
Chambers JH; Fleishaker JC
Biopharm Drug Dispos; 1994 May; 15(4):263-72. PubMed ID: 8068865
[TBL] [Abstract][Full Text] [Related]
18. Behavioral effects of alprazolam in humans.
Kelly TH; Foltin RW; Serpick E; Fischman MW
Behav Pharmacol; 1997 Feb; 8(1):47-57. PubMed ID: 9833000
[TBL] [Abstract][Full Text] [Related]
19. A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam.
Busto UE; Kaplan HL; Wright CE; Gomez-Mancilla B; Zawertailo L; Greenblatt DJ; Sellers EM
J Clin Psychopharmacol; 2000 Dec; 20(6):628-35. PubMed ID: 11106134
[TBL] [Abstract][Full Text] [Related]
20. The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects.
Allen D; Curran HV; Lader M
Eur J Clin Pharmacol; 1991; 40(4):355-62. PubMed ID: 2050170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
